---
figid: PMC3676662__fig-1
figtitle: The components of the trimolecular complex and therapeutic approaches for
  targeting
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC3676662
filename: fig-1.jpg
figlink: /pmc/articles/PMC3676662/figure/f1/
number: F1
caption: The components of the trimolecular complex and therapeutic approaches for
  targeting. The trimolecular complex consisting of a T cell receptor (TCR)–peptide–human
  leukocyte antigen (HLA) molecule. In order to block interactions, (1) a small molecule
  can occupy a pocket in a specific major histocompatibility complex (MHC) peptide
  binding groove, blocking peptide presentation to T cells, (2) a small molecule,
  such as glyphosine, can bind the MHC molecule and with an appropriate peptide induce
  a protective interleukin (IL)-10 response, (3) a monoclonal antibody can bind a
  specific peptide/MHC complex, thereby blocking T cell activation, or (4) a monoclonal
  antibody targets a specific TCR.
papertitle: 'Targeting the Trimolecular Complex: The Pathway Towards Type 1 Diabetes
  Prevention.'
reftext: Aaron W. Michels. Diabetes Technol Ther. 2013 Jun;15(Suppl 2):S2-8-S2-12.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9689067
figid_alias: PMC3676662__F1
figtype: Figure
redirect_from: /figures/PMC3676662__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3676662__fig-1.html
  '@type': Dataset
  description: The components of the trimolecular complex and therapeutic approaches
    for targeting. The trimolecular complex consisting of a T cell receptor (TCR)–peptide–human
    leukocyte antigen (HLA) molecule. In order to block interactions, (1) a small
    molecule can occupy a pocket in a specific major histocompatibility complex (MHC)
    peptide binding groove, blocking peptide presentation to T cells, (2) a small
    molecule, such as glyphosine, can bind the MHC molecule and with an appropriate
    peptide induce a protective interleukin (IL)-10 response, (3) a monoclonal antibody
    can bind a specific peptide/MHC complex, thereby blocking T cell activation, or
    (4) a monoclonal antibody targets a specific TCR.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HLA-C
  - TRBV20OR9-2
  - TRA
  - TRB
  - TRD
  - TRG
  - IL10
  - ENPP3
  - EVA1C
  - NDUFB9
  - NPM1
  - NDUFB4
  - NDUFA5
  - CYTH1
  - NDUFB7
  - NDUFB3
  - TNFAIP1
  - NDUFB6
  - DONSON
  - NDUFA6
---
